10,500 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Soros Capital Management LLC

Soros Capital Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 10,500 shares of the medical equipment provider’s stock, valued at approximately $5,158,000. Intuitive Surgical accounts for about 1.2% of Soros Capital Management LLC’s portfolio, making the stock its 26th biggest holding.

A number of other hedge funds have also bought and sold shares of ISRG. Waverly Advisors LLC increased its position in Intuitive Surgical by 27.1% during the first quarter. Waverly Advisors LLC now owns 2,552 shares of the medical equipment provider’s stock worth $1,018,000 after acquiring an additional 544 shares during the period. Kennedy Capital Management LLC acquired a new stake in Intuitive Surgical during the first quarter worth about $2,545,000. B. Riley Wealth Advisors Inc. grew its stake in Intuitive Surgical by 26.1% during the first quarter. B. Riley Wealth Advisors Inc. now owns 7,466 shares of the medical equipment provider’s stock worth $2,980,000 after buying an additional 1,545 shares in the last quarter. Creekmur Asset Management LLC grew its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares in the last quarter. Finally, Tidal Investments LLC grew its stake in Intuitive Surgical by 11.5% during the first quarter. Tidal Investments LLC now owns 16,560 shares of the medical equipment provider’s stock worth $6,609,000 after buying an additional 1,710 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. This trade represents a 3.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,647 shares of company stock worth $26,170,907 in the last quarter. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $542.10 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00. The firm has a 50 day moving average price of $506.81 and a two-hundred day moving average price of $466.29. The firm has a market cap of $193.09 billion, a price-to-earnings ratio of 87.15, a PEG ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the topic of a number of analyst reports. Piper Sandler reiterated an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Leerink Partners raised their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $526.06.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.